Alzheimer disease (AD) is characterized by accumulation of β-amyloid (Aβ) and tau, atrophy, and cognitive decline.1 The different brain changes can be monitored by CSF biomarkers, MRI, and PET. The gene discussed is MAPT; the disease is Alzheimer disease.